ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750054 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750054; 2) Community: the network communities that were significantly associated with the response to NSC 750054; 3) Molecule: the relationships between components within communities and NSC 750054; 4) MDR: the compounds that were significantly associated with the NSC 750054.

NSC Compound Enrichment Correlation
NSC 698090 Null 0.00725424828633685 0.34911691
NSC 731154 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno [1,2-c]isoquinoline 0.00725424828633685 0.081055323
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.00725424828633685 0.2969478
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.00741876119839022 0.40777632
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.00741876119839022 0.67665651
NSC 665514 Null 0.00741876119839022 0.5182708
NSC 678869 Benz[a]anthracene-6,6-dicarboxylic acid, 5,6,7,12- tetrahydro-2-methoxy-7,12-dioxo-, dimethyl ester 0.00741876119839022 0.34119368
NSC 681632 Camptothecin Derivative 0.00741876119839022 0.12912782
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.00741876119839022 0.60241851
NSC 718165 Null 0.00741876119839022 0.34517352
Total:59  Current:14    [First] [Prev] [Next] [Last]